Crocs Inc. Reports Fourth Quarter and Year End 2015 Financial Results
Feb 29, 2016 21:05 pm UTC| Business
NIWOT, Colo., Feb. 29, 2016 -- Crocs Inc. (NASDAQ:CROX) today reported financial results for the fourth quarter and year ended December 31, 2015. Fourth Quarter Highlights: Revenue was $208.7 million, in-line with...
Fox Factory Holding Corp. Announces Fourth Quarter and Full Year 2015 Financial Results
Feb 29, 2016 21:05 pm UTC| Business
Fourth Quarter 2015 Sales Increased 29.1% to $95.7 Million Gross Margin Increased 30 Basis Points to 29.9% Adjusted EBITDA Increased 32.9% to $16.1 Million Company Announces New $40...
Feb 29, 2016 21:05 pm UTC| Business
SEATTLE, Feb. 29, 2016 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth...
Ocera to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 21:05 pm UTC| Business
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Feb. 29, 2016 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced...
Greatbatch, Inc. Reports 2015 Fourth Quarter and Full Year Results
Feb 29, 2016 21:05 pm UTC| Business
FRISCO, Texas, Feb. 29, 2016 -- Greatbatch, Inc. (NYSE:GB) today announced results for its fourth quarter and full-year ended January 1, 2016. Three Months EndedYear EndJanuary 1,January 2,%January 1,January...
Five9 to Present at the Pacific Crest 11th Annual Emerging Technology Summit on March 2, 2016
Feb 29, 2016 21:05 pm UTC| Business
SAN RAMON, Calif., Feb. 29, 2016 -- Five9, Inc. (NASDAQ:FIVN), a leading provider of cloud software for the enterprise contact center market, announced today that members of its management team will present at the...
Nivalis Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results
Feb 29, 2016 21:05 pm UTC| Business
- Phase 2 Study Enrollment Progressing - Orphan Drug and Fast Track Designations Granted for N91115 in Cystic Fibrosis BOULDER, Colo., Feb. 29, 2016 -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS),a clinical-stage...